FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to gynaecology, and may be used for treating cystic fibrosis of the breast in females of reproductive age. That is ensured by prescribing the Burdock Seed preparation 3 capsules 3 times a day with meal for 6 weeks.
EFFECT: method provides higher clinical effectiveness in cystic fibrosis of the breast ensured by antiproliferative action of the preparation: accurate decrease in tumour necrosis factor alpha (TNF-α) responsible for stimulation of proliferative processes and increase in the content of interleukin-10 (IL10) showing antiproliferative action, and normalisation of a prolactin level with no side effects; and also provides extended range of products used for treating nonneoplastic diseases of the breast.
2 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING CYSTIC FIBROSIS OF BREAST IN FEMALES OF REPRODUCTIVE AGE | 2011 |
|
RU2456010C1 |
METHOD OF TREATING VEGETATIVE DYSFUNCTION ACCOMPANYING DIFFUSE CYSTIC FIBROSIS OF BREAST IN FEMALES OF REPRODUCTIVE AGE | 2011 |
|
RU2471494C2 |
METHOD OF TREATING DIFFUSE MAMMARY DYSPLASIA IN FEMALES OF REPRODUCTIVE AGE | 2013 |
|
RU2548723C1 |
METHOD OF DIFFERENTIAL DIAGNOSTICS OF FIBROCYSTIC DISEASE FORMS IN WOMEN WITH PRESERVED REPRODUCTIVE FUNCTION | 2010 |
|
RU2452389C1 |
METHOD FOR TREATING MASTOPATHY | 2002 |
|
RU2226400C1 |
METHOD FOR PREDICTION OF DEVELOPING COMPLICATIONS IN WOMEN SUFFERING CLIMACTERIC SYNDROME AND MASTOPATHY AND EMPLOYING HORMON REPLACEMENT | 2010 |
|
RU2426994C1 |
METHOD FOR PREDICTION OF HAEMATOGENIC METASTASIS IN BREAST CANCER PATIENTS AFTER ANTICANCER TREATMENT | 2010 |
|
RU2436099C1 |
METHOD FOR TREATMENT OF MASTOPATHY | 2003 |
|
RU2233669C1 |
COMPOSITION FOR INCREASING CONTENT OF HIGHLY DIFFERENTIATED CELLS IN BREAST ADENOCARCINOMA | 2018 |
|
RU2697199C1 |
METHOD FOR TREATING CHRONIC ANOVULATION AND PREVENTING SYNDROME OF OVARIAN HYPERSTIMULATION | 1999 |
|
RU2201225C2 |
Authors
Dates
2012-07-20—Published
2011-02-11—Filed